Strong Correlation Between Results of Fluorescent in Situ Hybridization and Immunohistochemistry for the Assessment of the ERBB2 (HER-2/neu) Gene Status in Breast Carcinoma

Modern Pathology - United Kingdom
doi 10.1038/modpathol.3880228
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Impact of Polysomy 17 on HER-2/neu Immunohistochemistry in Breast Carcinomas Without HER-2/neu Gene Amplification

Journal of Molecular Diagnostics
Forensic MedicinePathologyMolecular Medicine
2003English

Comparison of Immunohistochemistry and Fluorescence in Situ Hybridization for the Analysis of Her2/Neu and Topoisomerase Ii-Alpha Status in Human Breast Cancer

Turk Patoloji Dergisi
Forensic MedicinePathology
2010English

Differential Gene Expression in Ductal Carcinoma in Situ of the Breast Based on ERBB2 Status

Cancer Control
MedicineOncologyHematology
2017English

Study on Histopathological Correlation With ER, PR, and HER 2 Neu Receptor Status in Breast Carcinoma and Its Prognostic Importance

SSR Institute of International Journal of Life Sciences
2019English

Immunohistochemical Evaluation of Her-2/Neu Overexpression in Breast Carcinoma in Mosul

Annals of the College of Medicine, Mosul
2008English

Correlation Between Protein and Gene Expression of HER-2 and Topoisomerase 2a in Infiltrative Ductal Breast Carcinoma

English

Association Between Tumour Characteristics and HER-2/neu by Immunohistochemistry in 1362 Women With Primary Operable Breast Cancer

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2005English

Correlation of Histological Grade With Harmone Receptors and Her 2 Neu in Carcinoma Breast - A Tertiary Centre Study

International Journal of Contemporary Medical Research [IJCMR]
2018English

MET Gene Status in Malignant Mesothelioma Using Fluorescent in Situ Hybridization

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy